Latest News & Features
Big Pharma
Payments mark the sixth and seventh made to resolve price-fixing charges | Teva donates $50 million in drugs to humanitarian organisations. 24 August 2023
Big Pharma
Indian drugmaker had challenged PTAB decision that patent for new version of ruxolitinib was invalid as obvious | Decision hands a victory to US rival. 24 August 2023
Big Pharma
Biologics patent attorney aims to strengthen the firm’s global patent networks. 22 August 2023
Big Pharma
The pharmaceutical company agreed to pay millions to resolve a multi-district antitrust suit brought by more than 40 US state attorneys | Company sued over alleged actions aimed at preserving the monopoly of anti-addiction drug. 22 August 2023
Big Pharma
UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes. 22 August 2023
Biotechnology
Judges uphold PTAB decision invalidating Incept patents related to use of biodegradable filler in radiation treatment | Swedish firm Palette had challenged patents through inter partes review. 17 August 2023
Big Pharma
Patent-in-suit relates to a synthetic drug used to treat nicotine dependence | Development comes after USFood and Drug Administration sets new guidelines forcing the withdrawal of another big pharma firm’s rival drug. 10 August 2023
Medtech
Dispute centred on alleged infringement of several patents related to keyhole surgery | Big pharma company acquired defendant firm in $3.4bn deal four years ago. 10 August 2023
Big Pharma
US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival. 8 August 2023
Big Pharma
GSK argues that its US rival knew of its patented technology seven years after research began | Blockbuster respiratory vaccines, world’s first of their kind, received US approval in May. 7 August 2023